Overcoming Pharmacy Barriers to Buprenorphine Access
May 9, 2024
2:00 pm
3:00 pm
ET
Presenter(s):
Lucas Hill, PharmD, FCCP

Target Audience: This activity was developed to meet the needs of physicians, nurses, pharmacists and interprofessional healthcare providers.

Discussion is designed to promote interactivity through an informal “round table” conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues.

Jointly Accredited Provider

In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit for this activity is designated for learners in the following ways:

IPCE Credit

IPCE Credit

This activity was planned by and for the healthcare team, and learners will receive 1 (one) Interprofessional Continuing Education credits for learning and change.

Pharmacists

This activity has been approved for 1 hours of pharmacy continuing education credit. The approval numbers issued are Universal Activity Numbers:JA4008192-0000-24-014-L01-P   (pharmacy). 

Physician Designation Statement

American Academy of Addiction Psychiatry designates this live activity for a maximum of one (1) AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Health Professionals

Participants will receive a Certificate of Attendance stating this program is designated for 1.0 hour AMA PRA Category 1 Credit™. This credit is accepted by the AAPA.

Organizer(s):
American Academy of Addiction Psychiatry